CING tests around 1,700 samples from thalassaemia patients annually

The Cyprus Institute of Neurology and Genetics (CING) plays a central role in the research, treatment and prevention of thalassaemia, according to the Molecular Genetics Thalassaemia Department, which states that around 1,700 samples of thalassaemia patients and about 110 of the types of hemoglobinopathies are examined annually.

In its press release marking World Thalassaemia Day on 7 May, the Department says that in embracing the need, which is the focus of World Thalassaemia Day 2024, which has the theme "Empowering Lives, Embracing Progress: Equitable and Accessible Thalassaemia Treatment for All" and the need for affordable and effective treatment for thalassaemia, it carries out research programmes focused on the development of gene therapy for thalassaemia.

It further notes that people born with thalassaemia, as long as they have access to regular medical monitoring and receive treatment, can be expected to have a near-normal life expectancy and quality of life. However, the press release notes that the complete recovery of people with thalassaemia is achieved through a bone marrow transplant from a compatible donor.

It adds that on an annual basis, in the Molecular Genetics Thalassaemia Department of the CING, around 1,700 samples from thalassaemia patients are examined and around 110 prenatal genetic diagnoses of all types of hemoglobinopathies (beta-thalassaemia, alpha-thalassaemia, sickle cell anaemia, etc.) are carried out.

Since 2016, the Molecular Genetics Thalassaemia Department together with the thalassaemia clinics has been recognised by the Ministry of Health as a Reference Centre for Hemoglobin Diseases in Cyprus and as a healthcare provider within the European Reference Network EuroBloodNet.

It is also clarified that the research in the Molecular Genetics Thalassaemia Department is focused on the most common beta-thalassemia mutation in Cyprus called HBBIVSI-110 and it causes a decrease in beta-globin.

On the occasion of World Thalassaemia Day, the Molecular Genetics Thalassaemia Department reaffirms its commitment to promoting research and education and supporting policies that prioritise the well-being of people with thalassaemia.

The Cyprus Institute of Neurology and Genetics states that it is honouring World Thalassaemia Day by illuminating its building in red.

(Source: CNA)